STRATEGIC COLLABORATION TO BUILD SUSTAINABLE BIOTECH PERFORMANCE
This page extends the conversation from Suppliers' Day 2026. Explore the technical proof behind our three collaboration pillars and discover how yeast-based nutrients drive measurable outcomes for Life Science and Health Care.
A GLOBAL PARTNER, A LOCAL ALLY
Collaboration with Procelys by Lesaffre is more than just a concept—it’s a dynamic process leading to real-world results. Through open dialogue, co-creation, and continuous optimization, we turn shared visions into solutions that align with your strategic goals. With each step, we prioritize delivering outcomes aligned with research innovation, operational efficiency, and sustainable practices.
SCIENCE-POWERED INNOVATION
Bringing ideas to life
Deep expertise in biology and fermentation,
cutting-edge technologies, and data-driven
approaches to co-create the innovative
solutions you need.
Catalyzing fitting solutions everywhere
tailored support for R&D to operation teams.
Accelerate the trajectory
A common vision and yeast-based solutions, as
strong foundations to contribute to your
sustainability goals.
adapted for the growth of microorganisms, including fungi and bacteria.
One integrated approach, three capabilities:
- Yeast expertise – Mastery of yeast biology and fermentation
- Advanced analytics – Identification of critical performance parameters
- Microorganism insight – Tailored nutrition for P. pastoris, S. cerevisiae, CHO cells, and diagnostic cultures
Strict anaerobic bioreactor conditions were evaluated using CO₂ or N₂ atmospheres and 1% or 10% inoculation.
pH kinetics, glucose consumption, and metabolite production demonstrate that gas selection drives fermentation kinetics, enabling reproducible, animal-free anaerobic processes.
Gas and inoculation selection in bioreactor
Kinetics of substrate consumption & main metabolites
production over 48h
With their uniquely designed composition, yeast peptones are essential for supporting the growth of various microorganism species in a wide range of culture media. They can be used alone or synergistically with meat and vegetable peptones to optimize the production of biopharmaceuticals such as biologicals, active pharmaceutical ingredients (API), and vitamins by recombinant and non-recombinant microorganisms. Alternatively, yeast peptones offer an ideal replacement for traditional peptones, enabling producers to create animal-free and allergen-free.
DEDICATED OFFER FOR BIOPHARMA
Ideal for manufacture of a range of biopharma products, including antibodies, antibiotics, vaccines, vitamins, and ready-to-use media, when you use ProCel® – our high-performance fermentation nutrients specifically designed for the biopharma industry.
How we collaborate:
- Co-development – Joint R&D from concept through validation
- Proof of concepts – Validated performance data in our application labs
- Quality alignment – Critical parameters (endotoxins, nitrogen), batch-to-batch consistency, formal quality agreements
- Global network – 7 manufacturing sites ensuring supply resilience
- Sustainability integration – Embedded in every collaboration
ILLUSTRATION OF PROOF-OF-CONCEPTS
Recombinant enzyme production optimization with yeast extract in P. pastoris
This experiment shows how yeast-based nutrients enriched protein production.
P. pastoris, grown in bioreactor, expressing Human Serum Albumin (HSA) on plasmid under control of the constitutive GAP promoter in chemically defined media with 8% of ProCel® 245 MG. The recombinant HSA yield increased 88% when the media is supplemented with a ProCel® 245 MG yeast extract.
Comparaison of biomass & recombinant protein production after 15h of growth
Results obtained for genetically modified Saccharomyces cerevisie strain producing GFP. The strain was grown in Micro Titer Plate at 28°C under agitation with 10 g/L Soy Peptone or Yeast Peptone 3 - in a culture media derived from CP broth. Better performance are observed with the yeast peptone.
Animal-free alternative to casein peptone for TSA formulations
B.subtilis - ATCC 6633
Sauries - ATCC 6538
C.albicans A- TCC 10231
We adapt the quality and compliance alignment with end application market, fueled by market insights , and of course customer specificities.
A common vision and yeast-based solutions, as strong foundations to contribute to your sustainability goals. Procelys by Lesaffre, as part of the Lesaffre group, considers sustainability as a key driver, as we for our collaborative innovation projects, focus on climate change targets.
Cross-BU Collaboration
Life science and health care
Accelerated Time-to-Market
through industrial validation
End-to-End Partnership
alignement and sustainability
Portfolio Diversification
market competitiveness
Advanced Technologies
and analytical platforms
Supply Chain Resilience
reliable supply and compliance
